RxDoctor Payments Data

Leah Thompson, NP

Nurse Practitioner · Canon City, CONPI 1164146734

Payments from drug & device makers

$1,512in general payments, 2019–2025

Across 71 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$473
  • AbbVie$287
  • Pfizer$253
  • Scilex Pharmaceuticals Inc.$204
  • Novo Nordisk$162
  • Lilly USA, LLC$40
  • plus $92 from 4 others

What the payments were for

  • Food & beverage$1,512100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,512 in reported general payments places this provider in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$32,316
Medicare patients
78
Services billed
333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl146$120,100
Xtampza ErOxycodone Myristate66$30,070
Nucynta ErTapentadol Hcl13$17,224
UbrelvyUbrogepant12$16,508
ZtlidoLidocaine16$15,369
Buprenorphine43$10,622
MovantikNaloxegol Oxalate27$10,504
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen223$9,499
OxycontinOxycodone Hcl12$8,727
SavellaMilnacipran Hcl13$7,193
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen181$6,919
Lidocaine14$5,063
Oxycodone Hcl199$3,682
Morphine Sulfate ErMorphine Sulfate116$3,204
Tramadol Hcl ErTramadol Hcl41$2,425

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er$473$167,394225 claims
AbbVieUbrelvy, Savella$287$23,70125 claims
Scilex Pharmaceuticals Inc.Ztlido$204$15,36916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Canon City

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →